-+ 0.00%
-+ 0.00%
-+ 0.00%

SURROZEN GRANTED PATENT FROM U.S. PATENT AND TRADEMARK OFFICE DIRECTED TO ANTIBODY-BASED MOLECULES TARGETING KEY RECEPTORS IN THE WNT PATHWAY

Reuters·05/14/2025 12:34:18

Please log in to view news